  The last few years have seen significant progress in xenotransplantation. Porcine xenograft survival in preclinical models continues to improve , accompanied by the adjustment of immunosuppression to more clinically realistic levels. The rapid uptake of CRISPR/Cas9 technology has accelerated the generation of new knock-in and knockout pigs , including animals null for the endogenous retrovirus PERV. This brief review presents a personal view of recent developments in the field.